Clonidine Patent Expiration
Clonidine is used for treating high blood pressure, chest pain, and heart failure. It was first introduced by Lavipharm Sa
Clonidine Patents
Given below is the list of patents protecting Clonidine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nexiclon Xr | US8623409 | Clonidine formulation | Sep 08, 2031 | Athena |
| Nexiclon Xr | US8337890 | Modified release formulations containing drug-ion exchange resin complexes | Apr 17, 2027 | Athena |
Clonidine's Family Patents
Explore Our Curated Drug Screens
Clonidine Generic API Manufacturers
Several generic applications have been filed for Clonidine. The first generic version for Clonidine was by Difgen Pharmaceuticals Llc and was approved on Aug 18, 2009. And the latest generic version is by Actavis Laboratories Ut Inc and was approved on May 6, 2014.
Given below is the list of companies who have filed for Clonidine generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS UT INC
Actavis Laboratories Ut Inc has filed for 3 different strengths of generic version for Clonidine. Given below are the details of the strengths of this generic introduced by Actavis Labs Ut Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG/24HR | system | Prescription | TRANSDERMAL | AB | May 6, 2014 |
| 0.2MG/24HR | system | Prescription | TRANSDERMAL | AB | May 6, 2014 |
| 0.3MG/24HR | system | Prescription | TRANSDERMAL | AB | May 6, 2014 |
2. DIFGEN PHARMS
Difgen Pharmaceuticals Llc has filed for 3 different strengths of generic version for Clonidine. Given below are the details of the strengths of this generic introduced by Difgen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3MG/24HR | system | Prescription | TRANSDERMAL | AB | Aug 18, 2009 |
| 0.1MG/24HR | system | Prescription | TRANSDERMAL | AB | Aug 18, 2009 |
| 0.2MG/24HR | system | Prescription | TRANSDERMAL | AB | Aug 18, 2009 |
3. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Clonidine. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG/24HR | system | Prescription | TRANSDERMAL | AB | Aug 20, 2010 |
| 0.2MG/24HR | system | Prescription | TRANSDERMAL | AB | Aug 20, 2010 |
| 0.3MG/24HR | system | Prescription | TRANSDERMAL | AB | Aug 20, 2010 |
4. MYLAN TECHNOLOGIES
Mylan Technologies Inc has filed for 3 different strengths of generic version for Clonidine. Given below are the details of the strengths of this generic introduced by Mylan Technologies.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG/24HR | system | Prescription | TRANSDERMAL | AB | Jul 16, 2010 |
| 0.2MG/24HR | system | Prescription | TRANSDERMAL | AB | Jul 16, 2010 |
| 0.3MG/24HR | system | Prescription | TRANSDERMAL | AB | Jul 16, 2010 |
Manufacturing Plant Locations New
Mylan Technologies's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Mylan Technologies as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||